Pulmonary macrophage function in systemic gadolinium chloride-pretreated rats

Area of Science:

• Immunology
• Toxicology
• Respiratory Medicine

Background:

• Pulmonary macrophages are crucial for lung immunity.
• Gadolinium chloride is known to inhibit Kupffer cells (liver macrophages).
• The effect of gadolinium chloride on pulmonary macrophages is not well-established.

Purpose of the Study:

• To investigate the efficacy of systemic gadolinium chloride pretreatment in inhibiting rat pulmonary macrophage function.
• To determine if gadolinium chloride affects phagocytosis and nitroblue tetrazolium reduction in alveolar and interstitial macrophages.

Main Methods:

• Rats were pretreated with gadolinium chloride (10 mg/kg or 20 mg/kg) intravenously 48 hours before sacrifice.
• Alveolar and interstitial macrophages were isolated.
• Phagocytosis and nitroblue tetrazolium reduction assays were performed.

Main Results:

• Gadolinium chloride administration at 10 mg/kg and 20 mg/kg showed no significant effect on pulmonary macrophage phagocytosis.
• Nitroblue tetrazolium reduction by pulmonary macrophages remained unaffected by gadolinium chloride pretreatment.
• These results indicate a lack of inhibitory effect on pulmonary macrophages at doses effective for Kupffer cell inhibition.

Conclusions:

• Systemic gadolinium chloride pretreatment does not inhibit the function of rat alveolar and interstitial macrophages.
• The dose and timing of administration that inhibit Kupffer cells do not translate to pulmonary macrophages.
• Gadolinium chloride is not a suitable agent for modulating pulmonary macrophage activity in vivo.